These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 15468085)
1. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome. Hunter CL; Bachman D; Granholm AC Ann Neurol; 2004 Nov; 56(5):675-88. PubMed ID: 15468085 [TBL] [Abstract][Full Text] [Related]
3. Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model. Lockrow J; Prakasam A; Huang P; Bimonte-Nelson H; Sambamurti K; Granholm AC Exp Neurol; 2009 Apr; 216(2):278-89. PubMed ID: 19135442 [TBL] [Abstract][Full Text] [Related]
4. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome. Granholm AC; Sanders LA; Crnic LS Exp Neurol; 2000 Feb; 161(2):647-63. PubMed ID: 10686084 [TBL] [Abstract][Full Text] [Related]
5. Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice. Seo H; Isacson O Exp Neurol; 2005 Jun; 193(2):469-80. PubMed ID: 15869949 [TBL] [Abstract][Full Text] [Related]
6. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Cooper JD; Salehi A; Delcroix JD; Howe CL; Belichenko PV; Chua-Couzens J; Kilbridge JF; Carlson EJ; Epstein CJ; Mobley WC Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10439-44. PubMed ID: 11504920 [TBL] [Abstract][Full Text] [Related]
7. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330 [TBL] [Abstract][Full Text] [Related]
8. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome. Lockrow J; Boger H; Bimonte-Nelson H; Granholm AC Behav Brain Res; 2011 Aug; 221(2):610-22. PubMed ID: 20363261 [TBL] [Abstract][Full Text] [Related]
10. Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice. Kelley CM; Powers BE; Velazquez R; Ash JA; Ginsberg SD; Strupp BJ; Mufson EJ J Comp Neurol; 2014 Apr; 522(6):1390-410. PubMed ID: 24178831 [TBL] [Abstract][Full Text] [Related]
11. Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. Gautier MK; Kelley CM; Lee SH; Alldred MJ; McDaid J; Mufson EJ; Stutzmann GE; Ginsberg SD Neurobiol Dis; 2023 Nov; 188():106332. PubMed ID: 37890559 [TBL] [Abstract][Full Text] [Related]
12. Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases. Contestabile A; Fila T; Bartesaghi R; Contestabile A; Ciani E J Neurochem; 2006 Apr; 97(2):515-26. PubMed ID: 16539660 [TBL] [Abstract][Full Text] [Related]
14. Maternal choline supplementation in a mouse model of Down syndrome: Effects on attention and nucleus basalis/substantia innominata neuron morphology in adult offspring. Powers BE; Kelley CM; Velazquez R; Ash JA; Strawderman MS; Alldred MJ; Ginsberg SD; Mufson EJ; Strupp BJ Neuroscience; 2017 Jan; 340():501-514. PubMed ID: 27840230 [TBL] [Abstract][Full Text] [Related]
15. Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen. Hunter CL; Bimonte-Nelson HA; Nelson M; Eckman CB; Granholm AC Neurobiol Aging; 2004 Aug; 25(7):873-84. PubMed ID: 15212841 [TBL] [Abstract][Full Text] [Related]
16. Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome. Granholm AC; Sanders L; Seo H; Lin L; Ford K; Isacson O Hippocampus; 2003; 13(8):905-14. PubMed ID: 14750653 [TBL] [Abstract][Full Text] [Related]
17. Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome. Granholm AC; Ford KA; Hyde LA; Bimonte HA; Hunter CL; Nelson M; Albeck D; Sanders LA; Mufson EJ; Crnic LS Physiol Behav; 2002 Nov; 77(2-3):371-85. PubMed ID: 12419414 [TBL] [Abstract][Full Text] [Related]
18. Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome. Corrales A; Martínez P; García S; Vidal V; García E; Flórez J; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N J Pineal Res; 2013 Apr; 54(3):346-58. PubMed ID: 23350971 [TBL] [Abstract][Full Text] [Related]
19. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine. Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766 [TBL] [Abstract][Full Text] [Related]
20. Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome. Powers BE; Velazquez R; Kelley CM; Ash JA; Strawderman MS; Alldred MJ; Ginsberg SD; Mufson EJ; Strupp BJ Brain Struct Funct; 2016 Dec; 221(9):4337-4352. PubMed ID: 26719290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]